Global Gastroparesis Market Trends and Growth Analysis 2025–2029

Global Gastroparesis Market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Gastroparesis Industry Compare Between 2025 And 2029?

The gastroparesis market size has shown consistent expansion in recent years. It is projected to increase from $6.84 billion in 2024 to $7.15 billion in 2025, with a compound annual growth rate (CAGR) of 4.6%. This historical growth can be linked to an aging population, the rising prevalence of diabetes, a better understanding of gastrointestinal disorders, developing treatment protocols, and increasing awareness about gastroparesis.

The gastroparesis market size is anticipated to undergo significant expansion over the next few years. It is forecast to reach $8.78 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.3%. The market’s growth during this period can be attributed to the creation of innovative therapeutic alternatives, the broader application of personalized medicine approaches, the integration of digital health solutions, enhancements in healthcare infrastructure, and an increased emphasis on prompt diagnosis. Prominent trends for the forecast period include progress in gastric electrical stimulation therapy, expanding research in stem cell therapy, the adoption of minimally invasive surgical procedures, wider usage of wearable health monitoring devices, and a focus on care models centered around patients.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

Which Major Market Drivers Are Shaping The Future Of The Gastroparesis Market?

Increased spending on healthcare is anticipated to drive the expansion of the gastroparesis market in the future. Healthcare spending denotes the overall funds dedicated to health services, encompassing costs for hospitals, medical practitioners, nursing, dental services, pharmaceuticals, and public health programs. This rise in healthcare spending stems from several elements, including an aging demographic, advancements in medical technology, a greater occurrence of chronic conditions, and increased patient demands for enhanced healthcare provisions. The augmented healthcare expenditure positively impacts the gastroparesis market by offering increased financial backing for research and development, broadening available treatment options, and improving patient access to specialized medical care. As an illustration, a report from the UK government department, the Office for National Statistics, indicated that in May 2023, UK healthcare spending grew by 5.6% between 2022 and 2023, contrasting with a 0.9% increase in 2022. In 2023, the total healthcare expenditure in the UK reached approximately $317.63 billion (£292 billion). Consequently, the expanding healthcare expenditure is a key driver for the gastroparesis market.

What Are The Major Segment Types Covered In The Gastroparesis Market?

The gastroparesismarket covered in this report is segmented –

1) By Treatment Modality: Medications; Dietary Modifications; Medical Devices; Other Therapies

2) By Gastroparesis Type: Idiopathic; Diabetic; Post- Surgical; Other Types

3) By Patient Demographics: Pediatric Gastroparesis; Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Other Distribution Channels

5) By End User: Hospitals And Clinics; Ambulatory Surgical Centers; Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents; Antiemetic Medications; Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets; Small, Frequent Meals; Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices; Enteral Feeding Tubes

4) By Other Therapies: Acupuncture; Behavioral Therapies; Nutritional Supplements

What Key Innovation Trends Are Fueling Advancements In The Gastroparesis Market?

Leading companies in the gastroparesis market are developing innovative devices to boost their profitability. Devices for treating gastroparesis are medical tools or equipment designed to help manage or alleviate the symptoms associated with gastroparesis, a condition characterized by delayed emptying of the stomach. For instance, in 2022, Enterra Medical Inc., a US-based medical device company, introduced enterra therapy for the treatment of gastroparesis. The Enterra Therapy system uses an implanted neurostimulator to generate gentle electrical pulses, providing potential relief for chronic nausea and vomiting symptoms linked to gastroparesis. This therapy is specifically for individuals aged 18 to 70 years who experience chronic, intractable (drug-refractory) nausea and vomiting related to gastroparesis of either diabetic or idiopathic origin.

Which Leading Companies Dominate The Gastroparesis Market Share?

Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Which Region Is Projected To Lead The Gastroparesis Market During The Forecast Period?

North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gastroparesis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Browse Through More Reports Similar to the Global Gastroparesis Market 2025, By The Business Research Company

Foundation Structure And Building Exterior Contractors Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/foundation-structure-and-building-exterior-contractors-global-market-report

Repair And Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Serviced Office Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/serviced-office-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model